AstraZeneca's Vaccine Candidate Produces Antibodies and T-Cell Protection for Up to One Year Medicine & Technology Oct 26, 2020 With AstraZeneca's vaccine trials resuming worldwide, results have shown good immune responses in young and older adults alike. However, trials are yet to resume in the United States as volunteers await their second dose.
Plato’s Long-Lost Grave Found Using AI To Decipher Herculaneum Scrolls; Greek Philosopher Had Been Sold Into Slavery: Report
UFOs Piloted by Spiritual Entities? Fox News' Tucker Carlson Makes Bizarre Claim, Suggests That They Do Not Behave According to Laws of Science
SPACE Small Dark Formations on the Red Planet's Surface Appear Like Spider in Photos Captured by ESA's Mars Express
SPACE Citizen Scientists Identify New Sample of Over 1,000 Hidden Asteroids in Hubble’s Archival Data
SPACE NASA Engineers Successfully Repair Voyager 1 After 5 Months of Troubleshooting 15 Billion Miles Away